BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Key Financial Ratios of Thyrocare Technologies (in Rs. Cr.) | Mar 15 | |
| Per Share Ratios | ||
| Basic EPS (Rs.) | 9.14 | |
| Diluted EPS (Rs.) | 9.14 | |
| Cash EPS (Rs.) | 11.26 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 61.81 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 61.81 | |
| Revenue from Operations/Share (Rs.) | 36.20 | |
| PBDIT/Share (Rs.) | 15.93 | |
| PBIT/Share (Rs.) | 13.38 | |
| PBT/Share (Rs.) | 13.38 | |
| Net Profit/Share (Rs.) | 8.71 | |
| NP After MI And SOA / Share (Rs.) | 8.95 | |
| Profitability Ratios | ||
| PBDIT Margin (%) | 43.98 | |
| PBIT Margin (%) | 36.95 | |
| PBT Margin (%) | 36.95 | |
| Net Profit Margin (%) | 24.06 | |
| NP After MI And SOA Margin (%) | 24.71 | |
| Return on Networth/Equity (%) | 16.36 | |
| Return on Capital Employed (%) | 21.00 | |
| Return on Assets (%) | 13.73 | |
| Total Debt/Equity (X) | 0.00 | |
| Asset Turnover Ratio (%) | 55.57 | |
| Liquidity Ratios | ||
| Current Ratio (X) | 15.16 | |
| Quick Ratio (X) | 14.15 | |
| Inventory Turnover Ratio (X) | 24.84 | |
| Dividend Payout Ratio (NP) (%) | 41.99 | |
| Dividend Payout Ratio (CP) (%) | 32.69 | |
| Earnings Retention Ratio (%) | 58.01 | |
| Cash Earnings Retention Ratio (%) | 67.31 | |
| Coverage Ratios | ||
| Interest Coverage Ratios (%) | -- | |
| Interest Coverage Ratios (Post Tax) (%) | -- | |
| Valuation Ratios | ||
| Enterprise Value (Cr.) | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | |
| EV/EBITDA (X) | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | |
| Retention Ratios (%) | 58.00 | |
| Price/BV (X) | 0.00 | |
| Price/Net Operating Revenue | 0.00 | |
| Earnings Yield | 0.00 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss